|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-25 |
|
Veke 21-24 |
|
Veke 21-23 |
|
Veke 21-22 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Bordetella parapertussis |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Mycoplasma pneumoniae |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Chlamydia pneumoniae |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Influensavirus A |
334 |
<5 |
|
|
368 |
<5 |
|
|
296 |
<5 |
|
|
246 |
<5 |
|
|
|
Influensavirus B |
334 |
<5 |
|
|
368 |
<5 |
|
|
296 |
<5 |
|
|
246 |
<5 |
|
|
|
Parainfluensavirus 1 |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Parainfluensavirus 2 |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Parainfluensavirus 3 |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
224 |
<5 |
|
|
233 |
<5 |
|
|
203 |
<5 |
|
|
188 |
<5 |
|
|
|
Humant metapneumovirus |
113 |
<5 |
|
|
105 |
<5 |
|
|
94 |
<5 |
|
|
98 |
<5 |
|
|
|
Rhinovirus |
113 |
9 |
8 % |
|
105 |
12 |
11 % |
|
94 |
11 |
12 % |
|
98 |
9 |
9 % |
|
|
SARS-CoV-2 |
400 |
<5 |
|
|
453 |
<5 |
|
|
364 |
<5 |
|
|
346 |
<5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-25 |
|
Veke 21-24 |
|
Veke 21-23 |
|
Veke 21-22 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Bordetella parapertussis |
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Mycoplasma pneumoniae |
173 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Chlamydia pneumoniae |
173 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Influensavirus A |
183 |
<5 |
|
|
145 |
<5 |
|
|
164 |
<5 |
|
|
126 |
<5 |
|
|
|
Influensavirus B |
183 |
<5 |
|
|
145 |
<5 |
|
|
164 |
<5 |
|
|
126 |
<5 |
|
|
|
Parainfluensavirus 1 |
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Parainfluensavirus 2 |
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Parainfluensavirus 3 |
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
179 |
<5 |
|
|
146 |
<5 |
|
|
158 |
<5 |
|
|
125 |
<5 |
|
|
|
Humant metapneumovirus |
172 |
<5 |
|
|
144 |
<5 |
|
|
151 |
<5 |
|
|
121 |
<5 |
|
|
|
Rhinovirus |
172 |
43 |
25 % |
|
144 |
42 |
29 % |
|
151 |
45 |
30 % |
|
121 |
31 |
26 % |
|
|
SARS-CoV-2 |
10054 |
20 |
0 % |
|
10008 |
46 |
0 % |
|
9007 |
55 |
1 % |
|
9387 |
48 |
1 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
01.07.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|